The growing push-back against the use of Hydroxychloroquine for Covid-19 treatment continues to grow as Ohio’s Board of Pharmacy joins the latest onslaught against hydroxychloroquine (HCQ) as a prophylactic. On July 29th Ohio’s Board of Pharmacy updated it’s rule regarding the potentially life saving drug Hydroxychloroquine. Effective July 30, 2020, BOP rule 4729:5-5-21 of the Administrative Code goes into effect. In general, the rule prohibits the use of hydroxychloroquine and chloroquine for the treatment or prevention of COVID-19. There are some exceptions: Paragraph “C” of the updated rule states: “this rule does not apply to prescriptions issued as part of a documented institutional review board-approved clinical trial to evaluate the safety and efficacy of the drugs to treat COVID-19.Prescriptions must include documentation that the patient is enrolled in a clinical trial. “
The Ohio Board of Pharmacy also cites the FDA’s caution against use of hydroxychloroquine for COVID-19 outside of the hospital setting or a clinical trial due to risk of heart rhythm problems. But that it does not apply to FDA-approved uses for malaria, lupus, and rheumatoid arthritis; which has many people scratching their heads as to why the double standard of this potential life saving drug that has been safely used for over 6 decades exists.
A new update on the ruling comes a day after America’s Frontline Doctors held a two-day summit on Capitol Hill Monday, July 27th. Dr. Stella Immanuel, a primary care doctor at Rehoboth Medical Center in Houston, Texas, said during the summit that she has treated more than 350 patients with COVID-19 by using a combination of hydroxychloroquine, zinc, and azithromycin, and characterized the combination of drugs as a “cure.” Videos of the doctors have since been removed from Twitter, Facebook, and YouTube among other sites on the night of July 27. Twitter representatives charged that the video contains “misinformation”.
In early July, treatment with Hydroxychloroquine cut the death rate significantly in sick patients hospitalized with COVID-19 (without heart-related side-effects). Conducted in Detroit Michigan, the study published by Henry Ford Health System showed that out of 2,541 patients, 460 died but the median age was 64 (53 –76) years old. According to data published by the Center of Disease Control, 8 out of 10 Covid-19 Deaths have been with adults 65 years and older. There is also substantial research regarding HCQ’s ability to be used as a preventative medication in addition to it being a primary treatment to those infected with COVID.
President Donald Trump has been reported to have taken hydroxychloroquine for two weeks earlier this year as a preventive measure. He told reporters that his own experience with the drug was positive, saying, “it’s safe. It doesn’t cause problems. I had no problem.” A study conducted in France showed the combination of hydroxychloroquine (HCQ) and azithromycin (AZ) used in the treatment of COVID-19 resulted in a good clinical outcome. Virological cure was obtained in 973 patients within 10 days (91.7%). Prolonged viral carriage was observed in 47 patients (4.4%) and negative by day 10.
With a continuous stream of positive pharmaceutical testing and a clear ability to save lives, many are beginning to ask themselves: “then why is this drug and information about it being censored by big tech and the MSM?” This is due to their well known status of being an “enemy of the people.” This censorship is not just about the virus, it is about trying to prolong the virus and its far-reaching effects on society. The election is in November; if they are able to prolong the hysteria and continue to shut down large gatherings, their attempts to hijack the results of the 2020 Election will have a much greater chance of success.